Philip Morris International announced that Medicago will supply up to 76 million doses of Covid-19 vaccine candidate to the Canadian government, subject to approval. – Reuters image is for illustration only
MEDICAGO, a biopharmaceutical company headquartered in Quebec City, announced that it reached an agreement with Public Services and Procurement Canada (PSPC) to supply up to 76 million doses of its vaccine candidate for Covid-19, subject to Health Canada approval.
Innovation, Science & Economic Development (ISED), another department of the Canadian federal government, will contribute C$173M to Medicago to support its on-going vaccine development and clinical trials, and for the construction of its Quebec City manufacturing facility.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
